Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Elective C-Section
NCT07013812Phase 4
Key facts
- Status
- Completed
- Start
- Nov 2023
- Primary completion
- Apr 2024
- Countries
- 1
- Sponsor
- Combined Military Hospital Multan
- Modality
- Small Molecules
- Drugs
- tranexamic acid
- Conditions
- hemorrhage
01
Overview
Phase 4, randomised, double-blind trial in hemorrhage comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Intraoperative Blood Loss. Started Nov 2023; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Tranexamic Acid
1g IV Tranexamic Acid
Placebo
5% Dextrose IV
03
Endpoints
Primary
Intraoperative Blood Loss
Beyond the preview
Go deeper on NCT07013812.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013812.